Xu H - Search Results

1

Improved stability of KGF by conjugation with gold nanoparticles for diabetic wound therapy.

Li S, Tang Q, Xu H, Huang Q, Wen Z, Liu Y, Peng C. Li S, et al. Among authors: xu h. Nanomedicine (Lond). 2019 Nov;14(22):2909-2923. doi: 10.2217/nnm-2018-0487. Epub 2019 Dec 3. Nanomedicine (Lond). 2019. PMID: 31791171

2

Mesenchymal Stem Cell Derived Exosomes Therapy in Diabetic Wound Repair.

Jing S, Li H, Xu H. Jing S, et al. Among authors: xu h. Int J Nanomedicine. 2023 May 22;18:2707-2720. doi: 10.2147/IJN.S411562. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37250470 Free PMC article. Review.

3

Placenta-derived mesenchymal stem cells promote diabetic wound healing via exosomal protein interaction networks.

Peng C, Xu H, Zhuang Q, Liu J, Ding Y, Tang Q, Wang Z, Yao K. Peng C, et al. Among authors: xu h. Wound Repair Regen. 2024 Sep-Oct;32(5):638-651. doi: 10.1111/wrr.13199. Epub 2024 Jul 18. Wound Repair Regen. 2024. PMID: 39022990

4

MSC-derived exosomal circMYO9B accelerates diabetic wound healing by promoting angiogenesis through the hnRNPU/CBL/KDM1A/VEGFA axis.

Wang Z, Xu H, Xue B, Liu L, Tang Y, Wang Z, Yao K. Wang Z, et al. Among authors: xu h. Commun Biol. 2024 Dec 26;7(1):1700. doi: 10.1038/s42003-024-07367-z. Commun Biol. 2024. PMID: 39725699 Free PMC article.

5

Antitumor activity of integrin α_Vβ₃ antibody conjugated-cationic microbubbles in liver cancer.

Li J, Zhou P, Xu H, Tian S, Liu W, Zhao Y, Hu Z. Li J, et al. Among authors: xu h. Transl Cancer Res. 2019 Jun;8(3):899-908. doi: 10.21037/tcr.2019.05.29. Transl Cancer Res. 2019. PMID: 35116829 Free PMC article.

6

Cutting Edge: Probiotics and Fecal Microbiota Transplantation in Immunomodulation.

Zeng W, Shen J, Bo T, Peng L, Xu H, Nasser MI, Zhuang Q, Zhao M. Zeng W, et al. Among authors: xu h. J Immunol Res. 2019 Apr 16;2019:1603758. doi: 10.1155/2019/1603758. eCollection 2019. J Immunol Res. 2019. PMID: 31143780 Free PMC article. Review.

7

Prognostic Factors and Treatment Strategies for Intrahepatic Cholangiocarcinoma from 2004 to 2013: Population-Based SEER Analysis.

Liu J, Zhong M, Feng Y, Zeng S, Wang Y, Xu H, Zhou H. Liu J, et al. Among authors: xu h. Transl Oncol. 2019 Nov;12(11):1496-1503. doi: 10.1016/j.tranon.2019.05.020. Epub 2019 Aug 22. Transl Oncol. 2019. PMID: 31446308 Free PMC article.

8

The Prognostic Value of a lncRNA Risk Model Consists of 9 m6A Regulator-Related lncRNAs in Hepatocellular Carcinoma (HCC).

Deng Z, Hou J, Xu H, Lei Z, Li Z, Zhu H, Yu X, Yang Z, Jin X, Sun J. Deng Z, et al. Among authors: xu h. Evol Bioinform Online. 2023 Jan 12;19:11769343221142013. doi: 10.1177/11769343221142013. eCollection 2023. Evol Bioinform Online. 2023. PMID: 36655172 Free PMC article.

9

Exercise-based cardiac rehabilitation for patients with coronary artery operation: a systematic review and meta-analysis based on current randomized controlled trials.

Shi Y, Xu H, Dong J. Shi Y, et al. Among authors: xu h. Int J Surg. 2025 Feb 4. doi: 10.1097/JS9.0000000000002268. Online ahead of print. Int J Surg. 2025. PMID: 39903572

10

GAI1 underlines the antagonism between gibberellin and jasmonic acid in modulating disease resistance.

Xu H, Tan M, Zhang B, Yan W, Zeng H. Xu H, et al. Physiol Plant. 2025 Jan-Feb;177(1):e70101. doi: 10.1111/ppl.70101. Physiol Plant. 2025. PMID: 39903059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46,041 results

Search Page

Filters